First Time Loading...

Prescient Therapeutics Ltd
ASX:PTX

Watchlist Manager
Prescient Therapeutics Ltd Logo
Prescient Therapeutics Ltd
ASX:PTX
Watchlist
Price: 0.048 AUD -4% Market Closed
Updated: May 2, 2024

Wall Street
Price Targets

PTX Price Targets Summary
Prescient Therapeutics Ltd

There are no price targets for PTX.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Prescient Therapeutics Ltd Competitors:
Price Targets
688278
Xiamen Amoytop Biotech Co Ltd
28% Upside
688105
Nanjing Vazyme Biotech Co Ltd
56% Upside
688520
Sinocelltech Group Ltd
62% Upside
ADMA
ADMA Biologics Inc
27% Upside
688336
Sunshine Guojian Pharmaceutical Shanghai Co Ltd
38% Upside
ZEAL
Zealand Pharma A/S
31% Upside
ALGEN
Genoway SA
65% Upside
4893
Noile-Immune Biotech Inc
184% Upside

Revenue
Forecast

Revenue Estimate
Prescient Therapeutics Ltd

For the last 8 years the compound annual growth rate for Prescient Therapeutics Ltd's revenue is 36%.

36%
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Prescient Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Prescient Therapeutics Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-95%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PTX's stock price target?
Not Available

PTX doesn't have any price targets made by Wall Street professionals.